Covid-19 Reinfection Rate Less Than 1% in Those With Severe Illness: Study

Covid-19 reinfection after an initial case is possible. But, reinfection is much lower when compared with the primary infection.

Patients with severe Covid-19 infection were found to have less than 1% chances of contracting the illness again, reveals a new study.

In a review of more than 9,000 U.S. patients with severe Covid-19 infection had an average reinfection time of 3.5 months after an initial positive test.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘Covid-19 reinfection after an initial case is possible. But, reinfection is much lower when compared with the primary infection.’

Those are the findings from a study conducted by researchers from the University of Missouri School of Medicine and MU Health Care.

The researchers teamed up with the MU Institute for Data Science and Informatics and the Tiger Institute for Health Innovation to review data from 62 U.S. health care facilities.

They found 63 of the 9,119 patients (0.7%) with severe COVID-19 infection contracted the virus a second time, with a mean reinfection period of 116 days. Of the 63 who were reinfected, two (3.2%) died.

COVID-19 can be Prevented by Common Cold
Exposure to the rhinovirus, the most frequent cause of the common cold, can protect against infection by the virus which causes COVID-19.

Patients categorized as non-white were at greater risk of reinfection than white patients.

"Our analysis also found asthma and nicotine dependence were associated with reinfection," said lead researcher Adnan I. Qureshi, MD, a professor of clinical neurology at the MU School of Medicine.

Impact of COVID-19 Pandemic on Sleep Duration
Slight increase in sleep duration in US cities from Fitbit user data during COVID-19 pandemic.

"However, there was a significantly lower rate of pneumonia, heart failure and acute kidney injury observed with reinfection compared with primary infection."

Qureshi defined reinfection by two positive tests separated by an interval greater than 90 days after the initial infection resolved, as confirmed by two or more consecutive negative tests.

71% People In India Believe in COVID-19 Vaccines
Amid a raging second wave of COVID-19 pandemic, over 71 per cent people in India have expressed faith in effectiveness of the vaccination drives undertaken to arrest the surge.

He analyzed data from patients who received serial tests between December 2019 and November 2020.

"This is one of the largest studies of its kind in the U.S., and the important message here is that COVID-19 reinfection after an initial case is possible, and the duration of immunity that an initial infection provides is not completely clear," Qureshi said.

In addition to Qureshi, the study authors include fellow MU School of Medicine collaborators Iryna Lobanova, MD, research specialist in the Department of Neurology; S. Hasan Naqvi, MD, associate professor of clinical medicine; William Baskett, graduate student; Wei Huang, graduate student; and Chi-Ren Shyu, PhD, Director, MU Institute for Data Science and professor of Informatics, Electrical Engineering and Computer Science.

Source-Eurekalert